	Prospectos 1 392 1 9756,	
metilprednisona 1 392 1 9745,	
ACR20 1 392 1 9712,	
(ESR) 1 392 1 9696,	
eritrocítica 1 392 1 9695,	
sedimentación 1 392 1 9694,	
proteína 1 392 1 9686,	
(68 1 392 1 9680,	
(TJC) 1 392 1 9678,	
tumefactas 1 392 1 9677,	
contadas)) 2 392 2 9672,9682,	
(66 1 392 1 9670,	
dolorosas 1 392 1 9667,	
articulaciones 4 392 4 9666,9671,9676,9681,	
(ACR) 1 392 1 9662,	
of 1 392 1 9660,	
College 1 392 1 9659,	
American 1 392 1 9658,	
sufrían 1 392 1 9640,	
elegibles 1 392 1 9639,	
TNF 1 392 1 9636,	
mostrado 1 392 1 9623,	
517 1 392 1 9619,	
incluyo 1 392 1 9618,	
comparativo 1 392 1 9614,	
multicéntricos 1 392 1 9607,	
demostró 1 392 1 9598,	
aliviar 1 392 1 9587,	
pacientes) 1 392 1 9572,	
(4 1 392 1 9571,	
356 1 392 1 9556,	
HAMA 1 392 1 9554,	
humano 1 392 1 9553,	
67 1 392 1 9543,	
apreciaron 1 392 1 9539,	
Datos 1 392 1 9534,	
83 1 392 1 9502,	
CHOP) 1 392 1 9497,	
relaciones 1 392 1 9481,	
ósea) 1 392 1 9479,	
extranodulares 1 392 1 9475,	
síntomas- 1 392 1 9470,	
albúmina 1 392 1 9469,	
microglobulina 1 392 1 9467,	
ECOG 1 392 1 9465,	
Arbor 1 392 1 9464,	
ajustado 2 392 2 9459,9531,	
IPI 2 392 2 9458,9530,	
(sexo 1 392 1 9456,	
46 1 392 1 9439,	
0028) 1 392 1 9427,	
76 1 392 1 9408,	
índice 1 392 1 9398,	
R- 1 392 1 9390,	
confirma 1 392 1 9384,	
respuesta) 1 392 1 9383,	
variables 1 392 1 9367,	
32 1 392 1 9360,	
68 1 392 1 9302,	
reducción 2 392 2 9285,9356,	
35 1 392 1 9258,	
instauración 1 392 1 9236,	
estatus 1 392 1 9189,	
(R-CHOP) 1 392 1 9135,	
ví 1 392 1 9755,	
padecían 1 392 1 9084,	
(edad 1 392 1 9077,	
399 1 392 1 9071,	
confirmar 1 392 1 9053,	
necesita 1 392 1 9047,	
proporcionó 1 392 1 9022,	
0071) 2 392 2 9010,9351,	
p=0 1 392 1 9009,	
p< 1 392 1 8983,	
(mediana 2 392 2 8973,8999,	
R-CHOP) 2 392 2 8933,9160,	
CR 1 392 1 8909,	
aplicable 1 392 1 8903,	
alcanzado; 1 392 1 8900,	
SG 1 392 1 8897,	
Análisis 1 392 1 8893,	
67% 1 392 1 8891,	
nuevo 2 392 2 8871,9239,	
56% 1 392 1 8867,	
NA 3 392 3 8863,8864,8898,	
(SG) 1 392 1 8862,	
(SLP) 1 392 1 8859,	
61% 1 392 1 8857,	
Reducción 1 392 1 8847,	
Kaplan- 1 392 1 8846,	
según 3 392 3 8842,9260,9653,	
Estimación 1 392 1 8841,	
Variable 1 392 1 8838,	
Observación 1 392 1 8830,	
%-75 1 392 1 8814,	
Un 2 392 2 8773,9320,	
eventos 5 392 5 8749,9220,9227,9255,9489,	
Kaplan­ 1 392 1 8743,	
curvas 3 392 3 8741,8844,9262,	
estimación 3 392 3 8738,9245,9295,	
%-72 1 392 1 8734,	
45 1 392 1 8733,	
(95 2 392 2 8730,8810,	
61 1 392 1 8714,	
experimentar 1 392 1 8703,	
Cox 1 392 1 8699,	
Utilizando 1 392 1 8693,	
relevante 2 392 2 8623,9208,	
completa; 1 392 1 8583,	
global; 1 392 1 8580,	
disponible; 1 392 1 8575,	
Abreviaturas 1 392 1 8572,	
tendencia 1 392 1 8558,	
estadística 1 392 1 8549,	
evaluada 1 392 1 8543,	
ratio 1 392 1 8537,	
hazard 1 392 1 8536,	
calculadas 1 392 1 8534,	
estimaciones 1 392 1 8532,	
0005 1 392 1 8521,	
16% 1 392 1 8518,	
0003 2 392 2 8514,8890,	
87% 1 392 1 8512,	
Eficacia 1 392 1 8507,	
mediana) 2 392 2 8506,8837,	
Fase 2 392 2 8486,8818,	
mejoró 1 392 1 8476,	
31 3 392 3 8454,8503,9171,	
fases 1 392 1 8443,	
siguió 1 392 1 9736,	
incluyó 2 392 2 8435,9152,	
final 3 392 3 8434,9149,9195,	
consistió 1 392 1 8397,	
(n=167) 2 392 2 8387,8390,	
distribuidos 1 392 1 8378,	
parcial 3 392 3 8371,8565,8586,	
consiguieron 2 392 2 8366,8907,	
334 1 392 1 8363,	
equilibrados 2 392 2 8345,9180,	
n=234) 1 392 1 8337,	
(R-CHOP 2 392 2 8336,9494,	
n=231) 1 392 1 8330,	
doxorrubicina 2 392 2 8326,9098,	
465 1 392 1 8308,	
aleatoriamente 2 392 2 8307,8379,	
distribuyeron 1 392 1 8306,	
prospectivo 1 392 1 8296,	
Global 1 392 1 8280,	
TFT 1 392 1 8268,	
Libre 2 392 2 8259,8265,	
Supervivencia 6 392 6 8258,8264,8279,8848,8860,8882,	
Progresión 2 392 2 8253,8261,	
Tiempo 3 392 3 8251,8270,8868,	
­ 5 392 5 8250,8257,8263,8269,8276,	
TP 1 392 1 8249,	
175 1 392 1 8248,	
IFN 1 392 1 8247,	
R-CHVP- 1 392 1 8246,	
FL2000 1 392 1 8245,	
42-meses 1 392 1 8242,	
87 1 392 1 8238,	
92 1 392 1 8234,	
105 1 392 1 8233,	
OSHO-39 1 392 1 8231,	
74 1 392 1 8230,	
47 1 392 1 8225,	
MCP- 1 392 1 8223,	
48-meses 1 392 1 8222,	
alcanzada 2 392 2 8219,8237,	
62 1 392 1 9418,	
20 2 392 2 8217,8872,	
96 2 392 2 8216,8224,	
90 1 392 1 8210,	
205 1 392 1 8208,	
GLSG'00 1 392 1 8206,	
18-meses 1 392 1 8205,	
162 1 392 1 8204,	
condujo 1 392 1 8616,	
M39021 1 392 1 8202,	
TSG 2 392 2 8198,8275,	
Respuesta 1 392 1 8195,	
Tasa 2 392 2 8193,8277,	
Mediana 4 392 4 8191,8196,8220,8239,	
Ensayo 1 392 1 8189,	
regímenes 1 392 1 8183,	
resume 1 392 1 8153,	
dependientes 1 392 1 8142,	
tasas 1 392 1 8137,	
mejorías 1 392 1 8133,	
CHVP/Interferon-) 1 392 1 8129,	
MCP 1 392 1 8128,	
secundarias 1 392 1 9368,	
(CHOP 2 392 2 8127,8931,	
distinto 1 392 1 8124,	
MabThera/Rituxan 1 392 1 8116,	
utilizó 1 392 1 8115,	
6años 1 392 1 8213,	
comparada 1 392 1 8093,	
centros) 1 392 1 8074,	
alto 1 392 1 9522,	
aleatorización 2 392 2 8609,8640,	
estratificado 1 392 1 8072,	
029; 1 392 1 8069,	
supervivencia 15 392 15 8061,8078,8148,8631,8746,8777,9029,9217,9252,9298,9328,9372,9376,9486,9492,	
respecto 1 392 1 8058,	
CVP; 1 392 1 8003,	
(57 1 392 1 7983,	
(80 1 392 1 7975,	
cuadrado) 1 392 1 7970,	
test 3 392 3 7968,8071,8556,	
0001 4 392 4 7967,8663,8856,8877,	
(p< 3 392 3 7965,8569,8661,	
RCnc 1 392 1 7960,	
(SJC) 1 392 1 9668,	
confirmada 1 392 1 7959,	
(RC 2 392 2 7955,8944,	
test) 5 392 5 7947,8017,8049,8665,8794,	
0001; 3 392 3 7945,8015,8047,	
p 1 392 1 7942,	
meses; 1 392 1 7941,	
(27 1 392 1 7936,	
(TFT) 1 392 1 7935,	
principal 4 392 4 7925,8627,9222,9699,	
respecta 1 392 1 7921,	
obtuvo 2 392 2 7909,9162,	
tratado 3 392 3 7906,7915,9269,	
53 3 392 3 7902,8081,8887,	
159 2 392 2 7888,8201,	
R-CVP 7 392 7 7887,7908,7974,7988,8034,8092,8203,	
321 1 392 1 7883,	
evaluó 3 392 3 7878,9549,9562,	
(R-CVP) 1 392 1 7863,	
1-5) 2 392 2 7847,9120,	
anti-linfoma) 1 392 1 9241,	
prednisolona 2 392 2 7842,9115,	
750 2 392 2 7826,9096,	
aleatorizado 2 392 2 7810,9067,	
abierto 3 392 3 7809,8297,9066,	
(12 1 392 1 7797,	
favorables 1 392 1 7786,	
retratamientos 1 392 1 7735,	
veces 1 392 1 7728,	
Dos 1 392 1 7723,	
tercer 1 392 1 7716,	
CHVP-IFN 1 392 1 8243,	
RP) 2 392 2 7961,8946,	
significa 1 392 1 7712,	
Tres 1 392 1 7693,	
objetiva 1 392 1 7672,	
58 1 392 1 7649,	
33 2 392 2 7613,8004,	
51 4 392 4 7607,7749,9002,9448,	
36 2 392 2 7600,8241,	
diámetro) 1 392 1 7579,	
única 2 392 2 7575,8401,	
(lesión 1 392 1 7574,	
39 1 392 1 7559,	
agrupados 1 392 1 7554,	
Con 1 392 1 7552,	
19 1 392 1 7527,	
localizaciones 1 392 1 9474,	
TTP 4 392 4 7525,7619,7762,7789,	
RC 5 392 5 7514,7609,7751,8516,8581,	
%; 3 392 3 7513,7608,7750,	
73 1 392 1 7512,	
95%;41 1 392 1 7509,	
(CI) 1 392 1 7507,	
(Intervalo 1 392 1 7504,	
57 3 392 3 7502,8766,9312,	
intravenosasemanal 1 392 1 7494,	
multicéntrico 3 392 3 7468,7646,8300,	
resistencia 1 392 1 7451,	
bcl-2 1 392 1 7450,	
positividad 1 392 1 7447,	
histológico 1 392 1 7446,	
pronósticos 1 392 1 7444,	
identificaron 1 392 1 7440,	
logística 1 392 1 7433,	
0186) 1 392 1 7422,	
59 1 392 1 7410,	
significativa 4 392 4 7380,8065,8620,9211,	
correlación 1 392 1 7378,	
apoyado 1 392 1 7427,	
Fisher) 1 392 1 7368,	
parámetros 1 392 1 8141,	
(test 1 392 1 7364,	
estadísticamente 3 392 3 7362,7379,9210,	
pequeños 1 392 1 9015,	
elevada 1 392 1 7352,	
LDH 2 392 2 7349,9468,	
bulky 5 392 5 7348,7459,7548,7565,9473,	
sexo 1 392 1 7337,	
Ni 1 392 1 7331,	
Meier 2 392 2 8744,9265,	
43 2 392 2 7325,7518,	
78 2 392 2 7322,8756,	
22 3 392 3 7304,8813,9006,	
meses) 5 392 5 7300,7536,7630,7773,7799,	
duración 7 392 7 7294,7894,8022,9214,9248,9325,9380,	
(definidas 1 392 1 7292,	
71 1 392 1 8096,	
quimioresistentes 1 392 1 7291,	
quimiosensible 1 392 1 7284,	
38 4 392 4 7272,7534,7742,8874,	
(53 1 392 1 7269,	
> 1 392 1 7266,	
cm 3 392 3 7264,7268,7577,	
grande 1 392 1 7260,	
lesión 1 392 1 7258,	
diámetro 1 392 1 7254,	
cuyo 1 392 1 7253,	
(58 1 392 1 7242,	
subtipo 1 392 1 7239,	
D 1 392 1 7233,	
Formulation) 1 392 1 7229,	
Working 1 392 1 7228,	
(International 1 392 1 7227,	
histológicos 1 392 1 7223,	
subtipos 1 392 1 7222,	
TRG 9 392 9 7216,7248,7276,7307,7499,7597,7739,8509,8576,	
13 3 392 3 7207,8037,9274,	
respondedores 5 392 5 7204,8965,8991,9035,9042,	
(TTP) 1 392 1 7200,	
proyectada 3 392 3 7195,7523,7760,	
(RP) 1 392 1 7192,	
parciales 1 392 1 7191,	
42 3 392 3 7187,8672,8853,	
(RC) 1 392 1 7184,	
56 2 392 2 7175,8808,	
- 4 392 4 7174,7511,7606,7748,	
IC; 1 392 1 8732,	
41 2 392 2 7172,9289,	
(IC95 3 392 3 7170,7602,7744,	
48 1 392 1 7168,	
intención 1 392 1 7162,	
(TRG/ORR) 1 392 1 7157,	
tasa 5 392 5 7153,7383,8076,8577,9692,	
quimiorresistente 4 392 4 7133,7486,7583,7665,	
166 1 392 1 7121,	
40 4 392 4 7089,7394,7843,9116,	
empieza 1 392 1 7066,	
periférica 2 392 2 7039,7065,	
finalizado 1 392 1 7021,	
(índices 1 392 1 9369,	
recuperaron 1 392 1 7008,	
comenzó 1 392 1 6999,	
repoblación 2 392 2 6995,7077,	
normal 2 392 2 6986,7350,	
Tras 2 392 2 6965,8446,	
apoptosis 1 392 1 6964,	
induce 1 392 1 6959,	
killer) 1 392 1 6942,	
(natural 1 392 1 6941,	
NK 1 392 1 6940,	
granulocitos 1 392 1 6936,	
(ADCC) 1 392 1 6923,	
(CDC) 1 392 1 6908,	
complemento 1 392 1 6907,	
dependiente 2 392 2 6905,6920,	
citotoxicidad 2 392 2 6904,6918,	
efector 1 392 1 6902,	
mediada 2 392 2 6900,6924,	
mecanismos 1 392 1 6894,	
inmune 1 392 1 6884,	
macrófagos 1 392 1 6937,	
reclutar 1 392 1 6879,	
Fab 1 392 1 6858,	
dominio 2 392 2 6857,6876,	
razón 1 392 1 6846,	
plasma 1 392 1 6839,	
receptores 1 392 1 6929,	
circula 1 392 1 6837,	
celular 4 392 4 6834,6899,6919,6962,	
elimina 1 392 1 6830,	
unión 4 392 4 6825,6851,6913,6949,	
internaliza 1 392 1 6822,	
tejidos 1 392 1 6816,	
pro-B 1 392 1 6809,	
linfomas 1 392 1 6786,	
95 2 392 2 6781,9505,	
maduros 1 392 1 6773,	
expresada 1 392 1 6766,	
específicamente 1 392 1 6757,	
une 2 392 2 6756,6862,	
L01XC02 1 392 1 6753,	
código 1 392 1 6751,	
Grupo 1 392 1 6747,	
semanal 6 392 6 7114,7462,7549,7592,7640,7689,	
Propiedades 1 392 1 6745,	
	5 1 392 1 6743,	
ESTE 1 392 1 6741,	
FARMACOLÓGICAS 1 392 1 6739,	
PROPIEDADES 1 392 1 6738,	
" 1 392 1 6736,	
superiores 1 392 1 6727,	
relacionada 1 392 1 6711,	
existe 1 392 1 6709,	
11% 1 392 1 6677,	
Cardiovascular 1 392 1 6666,	
curso 1 392 1 6665,	
evaluación 2 392 2 6656,8548,	
incremento 1 392 1 6652,	
actuales 1 392 1 6647,	
particularmente 1 392 1 6621,	
05 1 392 1 6607,	
llegó 1 392 1 6604,	
mayoritariamente 1 392 1 6585,	
afectaron 1 392 1 6584,	
paciente-año 2 392 2 6575,6609,	
9 8 392 8 6573,6706,7014,7535,7621,7976,8086,9003,	
CVP) 1 392 1 7889,	
pre-B 1 392 1 6770,	
0 18 392 18 6572,6606,7208,7944,7966,8014,8046,8068,8513,8520,8527,8570,8662,8865,8889,8984,9501,9504,	
respectivamente 3 392 3 6563,8011,9506,	
glucocorticoidesintravenosos 1 392 1 6562,	
(19 1 392 1 6553,	
24/127 1 392 1 6552,	
(28 1 392 1 6541,	
29% 1 392 1 8519,	
18/65 1 392 1 6540,	
De 2 392 2 6524,9555,	
intravenosos 1 392 1 6513,	
(22 1 392 1 6497,	
42/192 1 392 1 6496,	
5/149 1 392 1 6483,	
hallazgo 1 392 1 7424,	
régimen 3 392 3 6475,8121,8928,	
comparó 1 392 1 6470,	
MabThera; 1 392 1 6462,	
79/540 1 392 1 6453,	
hipertensión) 1 392 1 6449,	
tos 1 392 1 6440,	
estornudos 1 392 1 6434,	
(prurito 1 392 1 6428,	
indicativos 1 392 1 6420,	
HACAs 1 392 1 6386,	
repetida 1 392 1 6379,	
mostrar 1 392 1 6329,	
Ciclos 1 392 1 6306,	
anafilactoide 1 392 1 6305,	
Anafilaxia 1 392 1 6303,	
angioneurótico 2 392 2 6296,6436,	
26 3 392 3 7628,7746,7771,	
laringe 1 392 1 6286,	
sibilancias 1 392 1 6283,	
Rheumatology 1 392 1 9661,	
Broncoespasmo 1 392 1 6282,	
generalizado 2 392 2 6276,6298,	
lugar 1 392 1 6272,	
tratada 1 392 1 6254,	
significativas 3 392 3 6247,6599,8134,	
anteriormente 1 392 1 6243,	
tabulados 1 392 1 6242,	
músculo 1 392 1 6234,	
R-MCP 1 392 1 8232,	
espasmos 1 392 1 6233,	
superior 3 392 3 6231,6589,7964,	
24 4 392 4 6188,7072,9292,9715,	
* 1 392 1 6180,	
diferencia) 1 392 1 6172,	
ocurren 1 392 1 6163,	
incluye 1 392 1 6157,	
Esta 1 392 1 6155,	
musculoesquelétic 1 392 1 6149,	
nausea 1 392 1 6130,	
completas 2 392 2 7183,9401,	
compite 1 392 1 6848,	
Población 2 392 2 6118,6123,	
(tiempo 2 392 2 8637,8831,	
disminuyeron 2 392 2 6074,6981,	
produjeron 2 392 2 6044,6184,	
IWF 2 392 2 7226,7240,	
consideraron 1 392 1 6010,	
14 6 392 6 5979,7056,7515,8008,8686,8851,	
II 3 392 3 5969,6028,6115,	
incluida 1 392 1 5963,	
agrupada 2 392 2 5962,6119,	
ensayo 16 392 16 5954,6125,6465,7119,7467,7645,7709,7722,7731,7737,7808,8292,8445,9065,9609,9613,	
placebo 7 392 7 5951,6068,6090,6179,6493,6685,6703,	
tabla 3 392 3 5909,6156,8151,	
prednisona 1 392 1 5903,	
metilprednisolona; 1 392 1 5896,	
(10-25 1 392 1 5879,	
separadas 2 392 2 5867,7051,	
años; 1 392 1 5840,	
Más 1 392 1 5816,	
II) 1 392 1 5810,	
fase 13 392 13 5805,5809,5955,5968,6027,6114,6126,8173,8294,8304,8361,8471,8593,	
ciego 3 392 3 5801,9605,9616,	
investigó 1 392 1 5795,	
retratamiento 1 392 1 5750,	
15 5 392 5 5725,5906,6047,6353,9732,	
Sobredosis 1 392 1 6707,	
6% 1 392 1 5723,	
Existe 1 392 1 5700,	
confianza 1 392 1 7506,	
voluminosa 1 392 1 5697,	
Enfermedad 1 392 1 5696,	
jóvenes 1 392 1 5693,	
mediar 1 392 1 6886,	
similares 1 392 1 5684,	
Pacientes 1 392 1 5665,	
(8 2 392 2 9669,9679,	
clave 2 392 2 8156,8167,	
monoterapia) 1 392 1 5664,	
(MabThera 1 392 1 5662,	
Subpoblaciones 1 392 1 5659,	
60% 1 392 1 5631,	
proporción 3 392 3 5618,6693,7949,	
constante 1 392 1 5611,	
mantuvo 1 392 1 5610,	
LLN 2 392 2 5607,5627,	
aumentó 1 392 1 5602,	
(<7g/L) 1 392 1 5577,	
(LLN) 1 392 1 5576,	
inferior 1 392 1 5572,	
límite 1 392 1 5571,	
debajo 3 392 3 5569,5625,6983,	
descenso 1 392 1 5651,	
mediana 14 392 14 5561,5597,7194,7522,7617,7759,7891,8019,8448,8599,8667,8958,9164,9339,	
Niveles 1 392 1 5540,	
administró 3 392 3 5534,7866,9138,	
causaron 1 392 1 5524,	
perforación 1 392 1 5518,	
Gastrointestinales 1 392 1 5503,	
seguimiento 7 392 7 5501,5832,5855,7896,9049,9168,9334,	
ocurridos 1 392 1 5496,	
tres 5 392 5 5482,5797,7556,8108,9600,	
demostrado 2 392 2 6946,8131,	
cerebrovasculares 2 392 2 5457,5488,	
accidentes 1 392 1 5456,	
Neurológicos 1 392 1 5435,	
coronarias 1 392 1 5433,	
calidad 1 392 1 8936,	
(50 1 392 1 7301,	
arterias 1 392 1 5432,	
miocárdico 1 392 1 5427,	
incluido 1 392 1 5423,	
condiciones 1 392 1 5389,	
aguda 2 392 2 6424,6546,	
estuvieron 3 392 3 5386,8343,9178,	
contexto 1 392 1 5379,	
Todas 1 392 1 5372,	
5%) 2 392 2 5371,5485,	
(3 2 392 2 5368,6484,	
9%) 1 392 1 5361,	
(14 1 392 1 5358,	
flutter/fibrilación 1 392 1 5349,	
supraventricular 1 392 1 5345,	
fundamentalmente 1 392 1 5343,	
183 1 392 1 8244,	
3% 1 392 1 5304,	
izquierdo 1 392 1 5299,	
ventrículo 1 392 1 5298,	
comparable 2 392 2 5270,6694,	
trastornos 2 392 2 5264,5473,	
ventricular 1 392 1 5244,	
18 2 392 2 5219,8209,	
basal 2 392 2 5196,7448,	
nivel 2 392 2 5195,5599,	
volvió 1 392 1 5190,	
transitorio 1 392 1 5186,	
hiperviscosidad 1 392 1 5180,	
asociados 2 392 2 5178,6443,	
podrían 1 392 1 5176,	
IgM 2 392 2 5169,5188,	
séricos 1 392 1 5167,	
transitorios 1 392 1 5163,	
días 4 392 4 5907,7057,7846,9119,	
aumentos 1 392 1 5162,	
macroglobulinemia 1 392 1 5156,	
tardía 1 392 1 5137,	
prolongó 3 392 3 5114,7989,8955,	
comparación 8 392 8 5102,5312,5689,6176,8001,8655,8683,8724,	
88%) 1 392 1 5062,	
pivotal 1 392 1 7120,	
97% 1 392 1 5059,	
14%; 1 392 1 5057,	
24% 1 392 1 5054,	
(R-CVP 1 392 1 5053,	
79%) 1 392 1 5051,	
88 1 392 1 5049,	
brazos 2 392 2 5021,5072,	
hubo 3 392 3 5017,5405,5466,	
(<1 1 392 1 5012,	
baja 2 392 2 5011,6404,	
trombocitopenia 2 392 2 5009,5128,	
(PCR) 1 392 1 9689,	
únicas 1 392 1 6726,	
4%) 2 392 2 4999,5726,	
2%) 1 392 1 4992,	
vs 19 392 19 4991,4998,5050,5055,5060,5724,7244,7265,7271,7303,7324,7938,8497,8563,8566,8765,8829,8979,9005,	
5% 1 392 1 4990,	
trombocitopenias 1 392 1 4959,	
plasmáticas 1 392 1 6811,	
anemia 2 392 2 4953,5130,	
(25 1 392 1 5722,	
2% 2 392 2 4952,5925,	
3/4) 1 392 1 4948,	
(grado 4 392 4 4947,4988,4995,5047,	
neutropenia 6 392 6 4946,4994,5052,5082,5111,5136,	
leves 1 392 1 4938,	
aparecieron 1 392 1 4929,	
días; 1 392 1 9733,	
anomalías 1 392 1 4926,	
hematológico 1 392 1 4912,	
tipo 3 392 3 4911,7445,7564,	
evaluaban 1 392 1 5548,	
positivos 3 392 3 4907,6384,9570,	
VIH 1 392 1 4906,	
Kaposi 2 392 2 4881,4890,	
sarcoma 2 392 2 4879,4888,	
C 3 392 3 4846,7231,9687,	
progresiva 1 392 1 4840,	
multifocal 1 392 1 4839,	
JC 1 392 1 4837,	
Simple) 1 392 1 4835,	
Zóster 1 392 1 4831,	
Virus 2 392 2 4827,4833,	
(Citomegalovirus 1 392 1 4826,	
mg/m2/día 2 392 2 7844,9117,	
herpes 1 392 1 4825,	
regresión 2 392 2 7432,8697,	
familia 1 392 1 4824,	
potencialmente 1 392 1 6258,	
Ejemplos 1 392 1 4810,	
exacerbaciones 1 392 1 4781,	
reactivaciones 1 392 1 4779,	
nuevas 1 392 1 4778,	
virales 2 392 2 4774,4814,	
términos 2 392 2 4750,9027,	
acumulada 1 392 1 4748,	
observó 1 392 1 4746,	
globales 1 392 1 4736,	
elevadas 1 392 1 4732,	
observación 18 392 18 4727,5005,5281,5322,5585,5595,5649,8389,8452,8502,8603,8660,8692,8729,8772,8790,8833,9055,	
Comparando 1 392 1 4713,	
ó 3 392 3 4711,4742,5240,	
pacientes3 1 392 1 4710,	
4% 1 392 1 4707,	
Senotificaron 1 392 1 4701,	
zoster 1 392 1 4700,	
Herpes 2 392 2 4699,4834,	
candida 1 392 1 4695,	
localizadas 1 392 1 4693,	
notificó 3 392 3 4686,4980,5039,	
minoría 2 392 2 4673,4932,	
séricas 1 392 1 4669,	
disminución 1 392 1 4665,	
70-80% 1 392 1 4656,	
octavo 1 392 1 4640,	
considerablemente 1 392 1 4625,	
aproximó 1 392 1 6570,	
respiratoria 2 392 2 4615,5401,	
auricular) 1 392 1 4597,	
0001) 3 392 3 8571,8985,9243,	
(insuficiencia 1 392 1 4591,	
congestiva 1 392 1 4586,	
preexistentes 1 392 1 4577,	
notificaron 13 392 13 4565,4729,4942,5122,5132,5214,5233,5286,5746,5763,6451,6672,6687,	
10% 2 392 2 4544,4997,	
antimurino 1 392 1 9552,	
hipotensión) 1 392 1 4539,	
dispepsia 1 392 1 4521,	
evalúan 1 392 1 5327,	
hipertensión 4 392 4 4518,5231,6128,6129,	
dolor 2 392 2 4516,6228,	
prurito 2 392 2 4515,6297,	
garganta 2 392 2 4513,6439,	
cefalea 1 392 1 4510,	
fatiga 1 392 1 4509,	
Otros 1 392 1 4500,	
primeras 2 392 2 4489,6187,	
observaron 1 392 1 4481,	
sensorial 1 392 1 4447,	
hematotoxicidad 1 392 1 4438,	
control 3 392 3 4437,5930,6221,	
comparado 6 392 6 4433,5000,5362,5926,8478,9495,	
similar 5 392 5 4427,5735,5757,6212,6334,	
media 1 392 1 9249,	
adversos 1 392 1 4413,	
Incluidos 1 392 1 4402,	
asociadas 2 392 2 4394,5387,	
Observados 1 392 1 4376,	
finalización 1 392 1 4369,	
extranodal 1 392 1 7358,	
tiempos 1 392 1 4363,	
craneal 1 392 1 4359,	
Signos 1 392 1 4353,	
Raramente 1 392 1 4346,	
hematológicas 3 392 3 4333,4927,6993,	
véase 3 392 3 4317,4325,4335,	
observada 1 392 1 4311,	
alta 2 392 2 4310,5079,	
notifica 1 392 1 4306,	
Solo 1 392 1 4304,	
comunes 1 392 1 4301,	
criterios 2 392 2 4300,9655,	
NCI 1 392 1 4299,	
realizó 1 392 1 4286,	
Evento 1 392 1 8267,	
(uno 1 392 1 5804,	
""+"" 1 392 1 4278,	
marcadas 1 392 1 4276,	
neutropenica 1 392 1 4440,	
exceptuando 1 392 1 4273,	
28 4 392 4 7755,8228,8605,8834,	
grave) 1 392 1 4272,	
abdominal 1 392 1 6232,	
(de 1 392 1 4269,	
grados 2 392 2 4265,5677,	
cálculo 2 392 2 4252,4281,	
complementarias 1 392 1 4249,	
Exploraciones 1 392 1 4248,	
Lugar 1 392 1 4245,	
alteraciones 2 392 2 4242,6269,	
generales 2 392 2 4240,6267,	
urinarios 1 392 1 4238,	
renales 1 392 1 4236,	
oral 1 392 1 5904,	
conjuntivo 1 392 1 4234,	
musculoesqueleticos 1 392 1 4219,	
subcutáneo 2 392 2 4217,6294,	
tejido 3 392 3 4216,4222,6293,	
piel 2 392 2 4213,6290,	
gastrointestinales 2 392 2 4209,6137,	
mediastínicos 2 392 2 4207,6281,	
torácicos 2 392 2 4205,6279,	
respiratorios 2 392 2 4204,6278,	
vasculares 1 392 1 4202,	
cardiacos 6 392 6 4200,4589,5265,5284,6674,6689,	
60 3 392 3 7734,9079,9336,	
laberinto 1 392 1 4198,	
oculares 1 392 1 4192,	
nutrición 2 392 2 4174,6147,	
metabolismo 2 392 2 4170,6143,	
inmunológico 2 392 2 4167,6302,	
linfático 1 392 1 4163,	
l 1 392 1 4157,	
Trastornos 25 392 25 4155,4164,4168,4175,4187,4191,4193,4199,4201,4203,4208,4210,4218,4235,4239,5434,5502,6136,6141,6148,6151,6266,6277,6287,6299,	
infestaciones 3 392 3 4154,5100,6140,	
MedDRA 3 392 3 4151,4186,4233,	
sistema 8 392 8 4150,4162,4166,4185,4189,4232,6153,6301,	
órganos 3 392 3 4148,4183,4230,	
clasificación 3 392 3 4146,4181,4228,	
Base 3 392 3 4142,4177,4224,	
monoterapia/mantenimiento 1 392 1 4125,	
Resumen 3 392 3 4112,6093,8163,	
Tabla 6 392 6 4110,6091,8161,8482,8484,8816,	
""desconocidas"" 1 392 1 4109,	
denominan 1 392 1 4107,	
cuya 1 392 1 4100,	
causadas 1 392 1 4818,	
identificadas 1 392 1 4091,	
1/100) 1 392 1 4088,	
1/100 2 392 2 4078,5983,	
1/10); 2 392 2 4075,4080,	
intervalo 5 392 5 4064,5870,5999,7054,9730,	
decreciente 2 392 2 4058,5993,	
resumen 2 392 2 8489,8821,	
enumeran 2 392 2 4055,5990,	
sólo 4 392 4 4045,4290,5106,8902,	
incluidas 1 392 1 4036,	
abajo 5 392 5 4034,4320,4328,4338,5911,	
tablas 1 392 1 4032,	
incluyen 2 392 2 4018,6903,	
leucopenia 2 392 2 4987,5046,	
RAFs 9 392 9 4015,4090,4115,5673,5706,5730,5747,5764,5769,	
Otras 1 392 1 4014,	
Acontecimientos 1 392 1 4008,	
orden 2 392 2 4057,5992,	
tumoral) 1 392 1 3996,	
(incluyendo 2 392 2 3987,5242,	
u 2 392 2 3978,8388,	
frecuentes 8 392 8 3974,4073,4076,4083,5976,5981,6006,6249,	
virales) 1 392 1 3968,	
bacterianas 1 392 1 3966,	
30-55% 1 392 1 3956,	
LNH 8 392 8 3953,4120,7124,7474,7562,7652,8311,8462,	
ocho 1 392 1 3942,	
1% 4 392 4 3939,4634,4957,5315,	
menor 4 392 4 3937,4425,4567,4632,	
sustancialmente 1 392 1 3930,	
disminuyó 1 392 1 3929,	
relacionados 3 392 3 3925,4620,5183,	
ocurrieron 3 392 3 3915,4540,4894,	
frecuencia 9 392 9 3900,4066,4101,4255,4284,4308,4568,4570,6001,	
observadas 4 392 4 3897,3979,5918,6100,	
compara 3 392 3 7236,7287,9394,	
(RAFs) 1 392 1 3896,	
fármaco 2 392 2 3895,3976,	
1000 1 392 1 9724,	
inducción) 1 392 1 3880,	
(como 2 392 2 3867,4537,	
principalmente 3 392 3 3862,4377,4495,	
comercialización 3 392 3 3857,4098,4141,	
post 3 392 3 3856,4097,4140,	
basa 1 392 1 3843,	
no-Hodgking 1 392 1 3841,	
transmembrana 1 392 1 6763,	
exposición 4 392 4 6340,6378,6460,6641,	
normalidad 1 392 1 5575,	
global 10 392 10 3836,7156,8062,8149,8778,8861,9030,9299,9329,9493,	
perfil 2 392 2 3833,6331,	
-Hodgking 1 392 1 3831,	
Experiencia 4 392 4 3827,5777,7103,9573,	
probables 1 392 1 3822,	
indiquen 1 392 1 3817,	
fecha 1 392 1 3815,	
farmacológica 1 392 1 3807,	
taquicardia 3 392 3 4517,5243,5347,	
efectos 2 392 2 3793,3820,	
realizado 1 392 1 3789,	
máquinas 2 392 2 3785,3803,	
utilizar 2 392 2 3784,3802,	
Efectos 1 392 1 3777,	
dar 1 392 1 3758,	
basales 2 392 2 8351,9186,	
monas 1 392 1 3749,	
detectado 1 392 1 3743,	
cuenta 3 392 3 3729,4262,4289,	
teniendo 2 392 2 3727,4287,	
Sin 4 392 4 3725,5076,6341,6719,	
materna 2 392 2 3724,3733,	
leche 3 392 3 3723,3738,3747,	
excreta 2 392 2 3720,3735,	
desconoce 1 392 1 3716,	
Lactancia 1 392 1 3714,	
postnatal 1 392 1 3713,	
período 2 392 2 3712,5853,	
poblaciones 1 392 1 3706,	
presentaron 1 392 1 3701,	
nacidas 1 392 1 3695,	
animales 1 392 1 3694,	
crías 1 392 1 3692,	
intrauterina 1 392 1 3690,	
vómitos 1 392 1 4506,	
embriotoxicidad 1 392 1 3689,	
indicios 1 392 1 3687,	
(rango 3 392 3 7530,7624,7767,	
hallado 1 392 1 3686,	
tuvieron 2 392 2 5486,7359,	
cinomolgos 1 392 1 3682,	
monos 1 392 1 3681,	
llevados 1 392 1 3677,	
toxicidad 2 392 2 3676,4747,	
exactitud 1 392 1 7366,	
estudios 8 392 8 3674,3790,3855,4095,4138,4678,5026,5150,	
brazo 18 392 18 4430,4436,4682,4725,5003,5067,5279,5320,5929,6215,6220,8677,8690,8727,9268,9278,9307,9317,	
organismo 1 392 1 3664,	
permanencia 1 392 1 3659,	
contraceptivos 1 392 1 3652,	
métodos 1 392 1 3651,	
fértil 1 392 1 3648,	
edad 5 392 5 3647,7336,9457,9461,9533,	
R-CHOP 15 392 15 5058,5357,5411,5448,8214,8475,8498,8998,9044,9201,9271,9309,9346,9415,9508,	
supere 1 392 1 3630,	
esperado 1 392 1 3629,	
beneficio 7 392 7 3628,7911,8178,8781,8911,9024,9342,	
embarazada 1 392 1 3623,	
mujer 1 392 1 3622,	
motivos 1 392 1 3615,	
TAMO 1 392 1 7330,	
embarazo 1 392 1 3612,	
transitoria 1 392 1 3595,	
embargo 7 392 7 3590,3726,4419,5077,6206,6342,6720,	
embarazadas 1 392 1 3588,	
controlados 5 392 5 3585,5803,6683,6735,9603,	
expuestas 3 392 3 3574,3607,3698,	
madres 3 392 3 3573,3606,3697,	
SLE 2 392 2 8240,8262,	
nacidos 2 392 2 3571,3604,	
placentaria 1 392 1 3559,	
barrera 1 392 1 3558,	
17 2 392 2 7764,8211,	
fosfoproteína 1 392 1 6762,	
atraviesan 1 392 1 3556,	
Todos 1 392 1 9746,	
IgG 6 392 6 3555,3732,5542,5566,5601,5623,	
inmunoglobulinas 2 392 2 3554,4668,	
lactancia 2 392 2 3548,3753,	
Varicela 1 392 1 4830,	
Embarazo 2 392 2 3546,3549,	
pacientes-año 1 392 1 3542,	
relevantes 1 392 1 3535,	
clínicamente 6 392 6 3534,6246,6598,8064,8622,9207,	
periféricas 2 392 2 3529,6980,	
persistía 1 392 1 3523,	
4-6 1 392 1 3513,	
recibieron 17 392 17 3499,3511,3889,4866,5821,5844,5858,5899,7137,7487,7584,7714,7822,9091,9129,9719,9749,	
110 1 392 1 3497,	
cohorte 1 392 1 3491,	
pequeña 1 392 1 3490,	
terapéuticos 1 392 1 3484,	
monoclonales 2 392 2 3483,6750,	
sufrir 1 392 1 3471,	
(HAMA/HACA) 1 392 1 3469,	
mg/semana) 1 392 1 5880,	
anti-murinos 1 392 1 3466,	
0039 2 392 2 8792,8866,	
títulos 1 392 1 3462,	
farmacocinética 1 392 1 3450,	
(LMP)) 1 392 1 4841,	
modifica 1 392 1 3448,	
223 1 392 1 8215,	
coadministración 1 392 1 3444,	
interacciones 1 392 1 3439,	
Actualmente 1 392 1 3432,	
ocurridas 1 392 1 5138,	
interacción 1 392 1 3431,	
(p=0 5 392 5 7421,8791,9242,9350,9426,	
formas 1 392 1 3429,	
Interacción 1 392 1 3422,	
determinado 2 392 2 3563,7376,	
diferentes 3 392 3 3415,4362,8182,	
plazo 2 392 2 3359,6662,	
notificados 5 392 5 3341,4410,4421,6201,6208,	
autoinmune 1 392 1 3334,	
ambas 1 392 1 8442,	
diagnosticó 1 392 1 3297,	
les 1 392 1 3296,	
neuropatía 1 392 1 4358,	
inmunosupresora 2 392 2 3290,3356,	
historia 1 392 1 3287,	
tenían 2 392 2 3285,3342,	
vasculitis 1 392 1 3279,	
(LES) 1 392 1 3277,	
Eritematoso 1 392 1 3275,	
Lupus 1 392 1 3274,	
autoinmunes 4 392 4 3272,3284,3368,3414,	
sobredosis 1 392 1 6714,	
autorizadas 1 392 1 3263,	
indicaciones 2 392 2 3261,4896,	
espontánea 1 392 1 3247,	
Notificación 1 392 1 3246,	
frecuencias 5 392 5 4038,4068,4730,5044,5971,	
aumento 4 392 4 3243,5041,5185,9683,	
resultado 3 392 3 6910,8457,9515,	
sugerir 2 392 2 3241,6650,	
parecen 3 392 3 3240,6328,6649,	
existentes 1 392 1 3238,	
sólidos 1 392 1 3231,	
tumores 1 392 1 3230,	
desarrollo 1 392 1 3228,	
posible 2 392 2 3225,6352,	
excluir 2 392 2 3223,6350,	
neoplasias 3 392 3 3201,6636,6992,	
inmunomoduladores 1 392 1 3195,	
malignas 4 392 4 3192,3202,6617,6637,	
Neoplasias 2 392 2 3191,6616,	
última 4 392 4 3306,5147,7454,8540,	
hubiese 1 392 1 3187,	
FAME 2 392 2 3172,3503,	
biológico 1 392 1 3169,	
efectores 1 392 1 6880,	
agente 1 392 1 3168,	
administra 1 392 1 3166,	
Kaplan 1 392 1 9264,	
Ocurridas 1 392 1 4360,	
5) 2 392 2 3163,8948,	
TNF) 1 392 1 3154,	
(incluidos 2 392 2 3150,3504,	
FAMEs 2 392 2 3149,3512,	
secuencial 1 392 1 3146,	
totalmente 1 392 1 3141,	
suficientes 2 392 2 3134,3583,	
indicación 1 392 1 3124,	
incluidos 3 392 3 3121,7706,8468,	
distintos 1 392 1 3118,	
propensas 1 392 1 5390,	
concomitante 1 392 1 3111,	
rubor 1 392 1 4503,	
concomitante/secuencial 1 392 1 3096,	
vivas 1 392 1 3085,	
completado 1 392 1 3065,	
haber 1 392 1 3064,	
infecciosas 2 392 2 3059,3962,	
locales/nacionales 1 392 1 3048,	
directrices 1 392 1 3047,	
considerando 1 392 1 3038,	
vacunación 3 392 3 3031,3051,3061,	
toxicidad) 1 392 1 4303,	
revisar 1 392 1 3027,	
Edema 2 392 2 6275,6295,	
diferencias 4 392 4 5018,5123,5406,5467,	
linfocitos 7 392 7 3013,3093,3567,3708,6769,6871,6957,	
persista 2 392 2 3009,3089,	
relativos 2 392 2 3000,6623,	
hay 2 392 2 2998,3132,	
202 1 392 1 9159,	
potencial 3 392 3 2959,3633,6634,	
re-evaluado 1 392 1 2956,	
Antes 1 392 1 2941,	
manifieste 1 392 1 2930,	
convenientemente 1 392 1 2925,	
tratará 1 392 1 2924,	
predisponer 1 392 1 2910,	
(TAMO) 1 392 1 7319,	
subyacentes 1 392 1 2907,	
patologías 2 392 2 2906,4575,	
36% 1 392 1 5654,	
recidivantes 1 392 1 2901,	
extremarán 1 392 1 2887,	
bajos) 1 392 1 2884,	
CD8 1 392 1 2882,	
observa 2 392 2 7030,7079,	
CD4 1 392 1 2880,	
niveles 6 392 6 2878,3565,5166,5564,5622,7010,	
tengan 1 392 1 2877,	
hipogammaglobulinemia 1 392 1 2872,	
inmunodeficiencia 1 392 1 2868,	
aquéllos 1 392 1 2866,	
tuberculosis 1 392 1 2855,	
Fracaso 1 392 1 8272,	
mortales 6 392 6 2831,3252,4351,4404,4787,6603,	
infecciones 18 392 18 2827,2858,2900,2912,2961,3533,4692,4702,4735,4738,4752,4773,4813,5098,6222,6568,6583,6597,	
producido 1 392 1 2826,	
antihipertensiva 1 392 1 2814,	
medicación 1 392 1 2813,	
completarse 1 392 1 6966,	
temporalmente 1 392 1 2811,	
rigurosamente 1 392 1 2787,	
monitorizará 1 392 1 2786,	
derivadas 1 392 1 2773,	
cardiovasculares 4 392 4 2772,4009,5204,5216,	
complicaciones 1 392 1 2771,	
sopesará 1 392 1 2767,	
cardiopatía 1 392 1 2765,	
refiere 1 392 1 2762,	
resultando 1 392 1 2745,	
sintomática 1 392 1 2744,	
exacerbación 2 392 2 2743,4572,	
enfermedada 1 392 1 8892,	
preexistente 3 392 3 2736,4383,4891,	
miocárdica 1 392 1 2735,	
isquemia 2 392 2 2734,5300,	
controlada 1 392 1 2730,	
NYHA) 1 392 1 2724,	
III 8 392 8 2721,5806,5956,6030,6117,6127,8174,8295,	
existen 3 392 3 2707,3433,3581,	
independientemente 3 392 3 2702,7090,8926,	
adversa 1 392 1 2694,	
%) 17 392 17 2678,6455,6485,6498,6542,6554,7176,7246,7273,7305,7519,7614,7756,7977,7985,8735,8815,	
gastrointestinal 1 392 1 5519,	
posibles 2 392 2 3438,6895,	
(1 2 392 2 2677,5484,	
10/990 1 392 1 2676,	
empeoramiento 2 392 2 2651,6354,	
ocurre 1 392 1 2629,	
disponibles 2 392 2 2622,6346,	
análisis 11 392 11 7212,7430,8286,8431,8695,8774,8923,9148,9194,9321,9363,	
tratar 2 392 2 2607,7164,	
Después 1 392 1 2585,	
(p 5 392 5 2570,2870,8012,8044,8066,	
50% 3 392 3 2565,4462,8878,	
reanudar 1 392 1 2563,	
pudo 1 392 1 2562,	
suspender 1 392 1 2528,	
disminuir 1 392 1 2520,	
libre 10 392 10 6842,8632,8747,8849,8883,9218,9253,9373,9377,9487,	
general 2 392 2 2518,4937,	
sucesivas 1 392 1 2510,	
Según 1 392 1 8736,	
disminuye 2 392 2 2507,4624,	
afectados 1 392 1 2506,	
(fibrilación 1 392 1 5291,	
porcentaje 4 392 4 2503,5742,5759,9704,	
moderada 2 392 2 2501,2719,	
psiquiátricos 1 392 1 4176,	
significativamente 6 392 6 2474,6515,7963,7990,8477,8956,	
redujo 5 392 5 2473,6514,8712,8801,9436,	
químicos 1 392 1 2465,	
mediadores 1 392 1 2464,	
mediadas 1 392 1 2456,	
asocia 1 392 1 2447,	
Reacciones 9 392 9 2438,3825,3982,4449,4908,5203,6131,6181,6413,	
37 3 392 3 7471,8028,8976,	
frente 7 392 7 2432,3055,5034,6550,7408,9272,9310,	
Vacunación 1 392 1 2996,	
anamnésica 1 392 1 2431,	
farmacoterapéutico 1 392 1 6748,	
primaria 3 392 3 2429,8508,8550,	
generar 1 392 1 2425,	
arritmia 2 392 2 5236,5344,	
capacidad 3 392 3 2423,3780,3798,	
vivos 1 392 1 2411,	
esqueléticos 1 392 1 6235,	
vacunas 3 392 3 2408,3005,3084,	
RP 5 392 5 7517,7612,7754,8523,8584,	
vacuna 2 392 2 2405,2435,	
inmunización 1 392 1 2402,	
estudiado 2 392 2 2397,2421,	
criterio 2 392 2 2392,3397,	
etapas 1 392 1 7435,	
conforme 2 392 2 2389,3394,	
neurólogo 2 392 2 2388,3393,	
consulta 2 392 2 2383,3388,	
neurológicos 2 392 2 2379,3384,	
presenten 2 392 2 2377,3382,	
diferencial 2 392 2 2373,3378,	
diagnóstico 4 392 4 2372,3377,3487,7341,	
LMP 7 392 7 2369,3298,3317,3329,3348,3374,4025,	
posibilidad 2 392 2 2367,3372,	
traten 2 392 2 2358,3363,	
médicos 4 392 4 2356,2886,3025,3361,	
hematopoyéticas 3 392 3 2354,4809,6807,	
madre 3 392 3 2353,4808,6806,	
transplante 2 392 2 2350,4805,	
consistieron 1 392 1 6031,	
parte 2 392 2 2347,4802,	
recibido 10 392 10 2339,2685,2982,4794,5938,5950,6108,6529,6559,7698,	
LNH(ver 1 392 1 2329,	
mg/h) 1 392 1 2577,	
post-comercialización 1 392 1 2325,	
(LMP) 1 392 1 2321,	
Progresiva 2 392 2 2320,3256,	
Multifocal 2 392 2 2319,3255,	
Leucoencefalopatía 2 392 2 2318,3254,	
virus 5 392 5 2306,2410,4821,4836,4844,	
3/4 7 392 7 4989,4996,5048,5268,5682,5709,5772,	
infección 8 392 8 2302,2849,2935,3190,4323,4439,4441,5393,	
antecedentes 3 392 3 2290,2763,2898,	
notificación 1 392 1 2274,	
confusión 1 392 1 2271,	
factores 5 392 5 2269,3344,5451,7333,7443,	
considerarse 1 392 1 2268,	
subyacente 2 392 2 2262,3352,	
Tanto 1 392 1 2256,	
citotóxica 5 392 5 2255,2266,2286,2989,4872,	
expuestos 2 392 2 2251,4884,	
multiorgánica 1 392 1 4601,	
mayoría 13 392 13 2245,2334,2488,2555,3911,3965,4390,4479,4789,4858,4901,5529,7082,	
fulminante 1 392 1 2241,	
rituximab 19 392 19 2237,2279,2340,2983,3609,3661,3718,3744,4886,6058,6088,6174,6256,6381,6508,6534,6643,6860,6951,	
Ben 1 392 1 2233,	
hepatitis 8 392 8 2232,2240,2292,2309,2972,4022,4845,4855,	
raros 3 392 3 2228,2316,2967,	
médica 1 392 1 2221,	
rinitis 1 392 1 4514,	
práctica 1 392 1 2220,	
acuerdo 2 392 2 2217,9528,	
utilice 1 392 1 2281,	
prednisona) 1 392 1 2205,	
CVP 10 392 10 2201,5056,7824,7862,7917,7982,8043,8103,8126,8200,	
regular 2 392 2 2181,2211,	
total 5 392 5 2178,2215,7812,7881,9069,	
sangre 5 392 5 2177,2214,4159,7038,7064,	
recuentos 4 392 4 2175,2183,2212,6976,	
realizar 2 392 2 2174,2208,	
mielotoxicidad 1 392 1 2167,	
inducido 1 392 1 2166,	
confirmó 4 392 4 8779,8919,9196,9340,	
haya 1 392 1 2165,	
reducida 1 392 1 2162,	
grupos 9 392 9 2151,5409,5477,5580,5739,6086,8054,8340,9175,	
ósea 6 392 6 2147,2160,7318,7392,7404,7420,	
médula 7 392 7 2146,2159,7317,7391,7403,7419,9478,	
autólogo 2 392 2 2144,7315,	
trasplante 2 392 2 2143,7314,	
sometidos 2 392 2 2141,7310,	
21 2 392 2 2139,7604,	
utilizado 1 392 1 2137,	
limitada 2 392 2 2133,3207,	
población 4 392 4 2131,5961,6253,7160,	
clínica 5 392 5 2128,5786,7104,7671,9574,	
contraste 1 392 1 5481,	
supraventricular) 1 392 1 5246,	
puesto 1 392 1 2124,	
75 2 392 2 2121,8226,	
plaquetas 2 392 2 2119,2185,	
109/l 2 392 2 2117,2123,	
× 2 392 2 2116,2122,	
experimentaron 3 392 3 2691,3960,6543,	
< 11 392 11 2113,2120,4079,4087,5314,5984,7262,7298,7943,8013,8045,	
neutrófilos 1 392 1 2112,	
recuento 4 392 4 2110,7059,9664,9674,	
11 2 392 2 4223,8980,	
prudencia 2 392 2 2100,2889,	
mielosupresor 1 392 1 2097,	
Aunque 2 392 2 2090,9011,	
cardiotoxicidad 2 392 2 2085,4385,	
y/o 6 392 6 2084,2118,2462,2851,3170,4384,	
miocardio 5 392 5 2064,4558,4595,5295,5397,	
infarto 5 392 5 2062,4556,4593,5293,5394,	
auricular 5 392 5 2058,2753,4560,5292,5350,	
fibrilación 4 392 4 2057,2752,4559,4596,	
arritmias 3 392 3 2051,5336,5374,	
notificadas 12 392 12 2495,2514,3812,3977,4017,4116,4554,4753,5227,5376,6250,6481,	
pecho 5 392 5 2050,2749,3760,4582,5251,	
angina 4 392 4 2048,2747,4580,5249,	
dicha 1 392 1 2041,	
horas 4 392 4 2038,2816,4491,6189,	
antihipertensivos 1 392 1 2036,	
producir 2 392 2 2023,2798,	
atribuidas 1 392 1 2013,	
atribuibles 2 392 2 2002,6011,	
(197 1 392 1 9157,	
descrito) 1 392 1 1999,	
farmacodinámicas 1 392 1 6746,	
(anteriormente 1 392 1 1998,	
parecerse 1 392 1 1989,	
conducir 2 392 2 3782,3800,	
anafilaxia 1 392 1 1987,	
clínicas 1 392 1 1985,	
puedan 1 392 1 2909,	
manifestaciones 1 392 1 1984,	
alérgica 2 392 2 1977,2632,	
reacción 8 392 8 1976,2631,2693,4258,4268,6304,6423,6545,	
ocurriera 1 392 1 1974,	
antihistamínicos 2 392 2 1969,2616,	
= 1 392 1 8067,	
adrenalina 2 392 2 1968,2614,	
3/4%) 1 392 1 5014,	
trastorno 3 392 3 4446,5426,5429,	
decir 2 392 2 1967,2854,	
combatir 1 392 1 1961,	
utilizados 1 392 1 1959,	
versus 1 392 1 8789,	
medicamentos 4 392 4 1958,2605,3426,9758,	
inmediato 3 392 3 1956,2626,2921,	
Conviene 1 392 1 1952,	
típicamente 1 392 1 1944,	
presentan 1 392 1 1943,	
diferencia 3 392 3 1930,5923,8051,	
anafilácticas 2 392 2 1921,2598,	
hipersensibilidad 7 392 7 1919,1940,1965,2005,2603,2611,3476,	
casos 25 392 25 1915,2046,2226,2277,2314,2558,2830,2965,3251,3327,3340,4350,4403,4547,4551,4850,4893,4943,4985,5134,5234,5516,5523,5532,6602,	
notificado 15 392 15 1914,2008,2045,2225,2313,2596,2739,2964,3250,3313,3326,3593,4349,4771,4849,	
necesidad 4 392 4 1901,2172,2551,2808,	
(variable 1 392 1 9221,	
salina 2 392 2 1893,2543,	
oxígeno 2 392 2 1891,2540,	
ocasionalmente 1 392 1 1890,	
interrupción 1 392 1 1875,	
reversibles 2 392 2 1872,4940,	
Generalmente 1 392 1 1868,	
hipotensión 6 392 6 1865,2024,2799,4519,5229,6447,	
Chi- 1 392 1 7969,	
% 48 392 48 1836,4964,6048,6063,6078,6170,6782,7169,7171,7173,7180,7188,7243,7270,7302,7323,7326,7395,7411,7503,7510,7516,7601,7603,7605,7611,7743,7745,7747,7753,8087,8098,8199,8715,8731,8757,8767,8809,8811,9290,9304,9314,9361,9410,9420,9440,9449,9568,	
repite 1 392 1 1823,	
raramente 1 392 1 1821,	
signos 6 392 6 1818,2300,2931,3188,4455,9592,	
resueltos 2 392 2 1815,2580,	
Una 1 392 1 1813,	
descartados 1 392 1 1812,	
resuelto 1 392 1 1808,	
mejoría 4 392 4 1778,8619,9206,9512,	
Dado 3 392 3 1774,2019,2794,	
(15 1 392 1 6454,	
choque 1 392 1 1773,	
sintomático 1 392 1 1771,	
2) 5 392 5 1760,8510,8517,8524,8538,	
desarrollen 1 392 1 1750,	
aumentarse 1 392 1 1740,	
pronóstico 1 392 1 1737,	
mal 1 392 1 1736,	
enumera 1 392 1 5912,	
insuficiencia 6 392 6 1723,2717,4584,4600,4611,4614,	
historial 2 392 2 1721,2080,	
significativo 4 392 4 7363,7912,8782,9025,	
Mabthera 1 392 1 5535,	
iniciar 1 392 1 1714,	
hora 1 392 1 1711,	
manifiesta 1 392 1 1703,	
radiológica 1 392 1 1698,	
exploración 1 392 1 1697,	
visibles 1 392 1 1694,	
edema 5 392 5 1692,4562,4598,6284,6435,	
intersticial 1 392 1 1690,	
acompañado 2 392 2 1687,1863,	
muerte 3 392 3 1680,5526,6961,	
sufrieron 2 392 2 4470,5455,	
respiratorio 4 392 4 1677,1683,6226,6588,	
(LDH)y 1 392 1 1671,	
(<65 1 392 1 5694,	
dehidrogenasa 1 392 1 1670,	
Lactato 1 392 1 1669,	
elevación 1 392 1 1666,	
agudo 4 392 4 1665,1678,1684,5395,	
renal 2 392 2 1664,4612,	
hiperfosfatemia 1 392 1 1662,	
nervioso 2 392 2 4190,6154,	
hipocalcemia 1 392 1 1661,	
hiperpotasemia 1 392 1 1660,	
hiperuricemia 1 392 1 1659,	
asociado 3 392 3 1648,1674,9203,	
comparan 1 392 1 5028,	
oído 1 392 1 4195,	
angioedema 2 392 2 1643,4504,	
urticaria 1 392 1 1641,	
rigidez 3 392 3 1640,4499,6433,	
escalofríos 3 392 3 1639,4497,6431,	
fiebre 6 392 6 1638,4448,4496,5392,6429,6432,	
además 2 392 2 1636,4768,	
acompañada 1 392 1 1631,	
caracteriza 1 392 1 1626,	
El 27 392 27 1618,1681,1700,2442,2502,3832,5184,5741,6774,6856,7058,7393,7904,7986,8391,8430,8610,8795,8910,8949,9147,9193,9362,9397,9428,9507,9608,	
monitorizarse 1 392 1 1598,	
Estos 5 392 5 1595,3858,4492,4892,7782,	
extremando 1 392 1 1589,	
mujeres 3 392 3 3587,3645,3755,	
alternativas 1 392 1 1587,	
alcanzado 3 392 3 7668,7790,9709,	
descartado 1 392 1 1585,	
únicamente 1 392 1 1581,	
tratarse 1 392 1 1580,	
expresa 2 392 2 6777,6793,	
desarrollar 1 392 1 1570,	
(ITT) 1 392 1 7165,	
mayor 14 392 14 1568,1734,3899,4688,4982,5064,5095,5352,5702,6166,7218,7250,7255,7279,	
riesgo 20 392 20 1567,1733,2153,2769,2958,3199,3226,3245,3346,3632,5453,6654,8701,8803,9287,9358,9429,9443,9483,9526,	
80 2 392 2 8085,9081,	
109/l) 1 392 1 1562,	
25 2 392 2 1560,8227,	
( 10 392 10 1559,4074,4077,4084,4294,5667,5977,5982,6168,8499,	
estimada 1 392 1 4105,	
circulantes 1 392 1 1558,	
número 1 392 1 1554,	
· 3 392 3 3981,4001,4007,	
elevado 1 392 1 1553,	
masa 1 392 1 1548,	
Fc 2 392 2 6877,6930,	
gran 1 392 1 1547,	
precauciones 3 392 3 1538,1591,1742,	
Advertencias 1 392 1 1536,	
controladas 1 392 1 1533,	
cardiacas 5 392 5 1530,2052,4576,5337,5417,	
enfermedades 6 392 6 1529,3058,3271,3283,3367,3413,	
Association) 1 392 1 1527,	
York 1 392 1 1525,	
New 1 392 1 1524,	
IV 1 392 1 1521,	
(clase 2 392 2 1520,2720,	
cardiaca 6 392 6 1518,2083,2718,4382,4585,4592,	
Insuficiencia 1 392 1 1517,	
activas 1 392 1 1512,	
Infecciones 7 392 7 1509,2823,4002,4152,4646,6138,6564,	
activo 2 392 2 1480,1497,	
SLP 8 392 8 8221,8256,8636,8670,8896,8961,8975,9001,	
principio 2 392 2 1479,1496,	
Hipersensibilidad 2 392 2 1477,1494,	
Contraindicaciones 1 392 1 1474,	
C1q 1 392 1 6915,	
mejoren 1 392 1 1469,	
reduciendo 1 392 1 1457,	
proteínas 4 392 4 1490,1507,1928,2591,	
generalmente 5 392 5 1456,3521,4486,5189,6402,	
resuelven 1 392 1 1455,	
8) 8 392 8 1453,1862,2332,2486,2701,2835,2917,3219,	
(sección 1 392 1 1451,	
prednisona; 1 392 1 8329,	
moderado 1 392 1 1450,	
grado 17 392 17 1447,4296,4740,5013,5238,5267,5339,5419,5708,5733,5767,5771,7127,7338,7477,7568,7656,	
finalizar 1 392 1 1437,	
seriamente 1 392 1 1429,	
adversas 16 392 16 1424,1847,3811,3826,3893,3971,4053,4332,4909,5289,5915,5988,6004,6097,6161,6204,	
presentasen 1 392 1 1417,	
previa 1 392 1 1414,	
mitad 1 392 1 1407,	
momento 3 392 3 1397,3234,8283,	
A 4 392 4 1393,1929,7241,9291,	
resultados 6 392 6 1388,8105,8155,8166,8492,8824,	
valores 1 392 1 1382,	
normalización 1 392 1 1379,	
acontecimientos 9 392 9 4407,4412,4588,5283,5487,6198,6241,6673,6688,	
síntomas 18 392 18 1377,1471,1782,1820,1870,2378,2584,2933,3383,3924,4355,4457,4493,4501,4619,5182,6419,9589,	
remisión 2 392 2 1372,8368,	
reiniciarse 2 392 2 1367,1401,	
paciente 3 392 3 1365,2761,2928,	
ningún 2 392 2 1364,3314,	
<0 2 392 2 8855,8876,	
Bulky 3 392 3 5699,5714,5721,	
torácica 3 392 3 1362,1392,1699,	
Nd 4 392 4 8515,8522,8529,8573,	
radiología 2 392 2 1361,1391,	
pulmonar 7 392 7 1359,1693,1724,1729,1805,4563,4599,	
incluyeron 4 392 4 2239,4494,4502,6263,	
infiltración 4 392 4 1358,1689,1727,1804,	
adecuadas 1 392 1 1353,	
laboratorio 3 392 3 1352,1384,9536,	
pruebas 1 392 1 1350,	
lisis 8 392 8 1347,1655,1800,3995,4528,4604,6888,6898,	
miocárdica) 1 392 1 5301,	
posteriormente 2 392 2 1341,5603,	
evaluar 4 392 4 1340,3140,6631,8176,	
hipoxia 2 392 2 1331,1635,	
broncoespasmo 6 392 6 1329,1633,1867,4505,4538,6442,	
disnea 3 392 3 1327,1628,4520,	
especialmente 2 392 2 1326,2406,	
graves 18 392 18 1325,1425,1510,1531,1905,2828,2913,3972,4016,4293,4532,4590,4703,4775,4815,4944,5290,6690,	
evidencia 4 392 4 1322,1343,1356,7075,	
muestren 1 392 1 1321,	
IC 1 392 1 8812,	
inmediatamente 2 392 2 1314,1766,	
interrumpir 4 392 4 1313,1763,2033,2810,	
4) 5 392 5 1310,1516,2995,4029,8483,	
ensayos 29 392 29 2674,3137,3578,3850,3948,4133,4314,4416,4468,4915,5207,5325,5545,5782,5798,5966,6026,6112,6122,6313,6669,6682,6717,6733,7557,8109,8160,8170,9601,	
citoquinas 13 392 13 1306,1576,1623,1755,1829,1858,1911,1936,1997,2018,2461,3992,4610,	
liberación 13 392 13 1304,1574,1621,1753,1827,1856,1909,1934,1995,2016,2459,3990,4608,	
inicio 3 392 3 1299,5172,6192,	
detectar 2 392 2 1297,2299,	
monitorizados 3 392 3 1295,2296,3184,	
estrechamente 4 392 4 1294,1600,1791,3183,	
recomienda 2 392 2 2099,3080,	
posología) 1 392 1 1289,	
También 3 392 3 1280,3323,6943,	
irritación 2 392 2 4511,6437,	
difenhidramina 1 392 1 1273,	
paracetamol 1 392 1 1271,	
ej 3 392 3 1270,2571,2871,	
antihistamínico 3 392 3 1269,1888,2536,	
antipirético 3 392 3 1265,1886,2534,	
consistente 1 392 1 1262,	
sepsis 1 392 1 2856,	
Siempre 1 392 1 1257,	
intravenoso 1 392 1 1256,	
bolo 1 392 1 1255,	
rápida 1 392 1 1252,	
preparadas 1 392 1 1246,	
soluciones 1 392 1 1245,	
específica 1 392 1 1243,	
linfocitopenia 1 392 1 3600,	
vía 2 392 2 1242,2471,	
empleando 1 392 1 1240,	
preparada 1 392 1 1232,	
años) 4 392 4 1226,5669,5695,9082,	
astenia 2 392 2 4522,6237,	
65 2 392 2 1225,5668,	
medicamentosas 1 392 1 3440,	
Heart 1 392 1 1526,	
(> 1 392 1 1224,	
ancianos 4 392 4 1223,5666,5687,9073,	
ajustar 1 392 1 1217,	
requiere 1 392 1 1216,	
Ancianos 1 392 1 1213,	
ausencia 2 392 2 1206,7345,	
(162 1 392 1 7886,	
debido 2 392 2 1203,3654,	
adolescentes 1 392 1 1202,	
recomendado 2 392 2 1196,3108,	
pediatría 1 392 1 1192,	
Uso 2 392 2 1190,3095,	
(tabla 1 392 1 8947,	
especiales 2 392 2 1189,1539,	
Poblaciones 1 392 1 1188,	
perfundir 1 392 1 1164,	
posteriores 5 392 5 1159,1832,3933,5753,6397,	
ensayado 1 392 1 6724,	
Segunda 1 392 1 1152,	
incrementos 2 392 2 1139,1175,	
administración) 1 392 1 1111,	
Forma 2 392 2 1109,1227,	
agudas 4 392 4 1104,6034,6391,6414,	
hijos 1 392 1 3763,	
gravedad 6 392 6 1100,2479,2498,4060,5995,6520,	
incidencia 25 392 25 1097,2476,3531,3921,4424,4617,4689,4983,5007,5080,5096,5126,5261,5334,5470,5671,5703,5728,6167,6211,6388,6517,6566,6595,6633,	
reducir 2 392 2 1095,1611,	
intravenosa30 1 392 1 1089,	
metilprednisolona 1 392 1 1088,	
Los 28 392 28 1076,1290,1544,1718,2355,2604,2885,3024,3193,3280,3339,3360,3459,3509,4405,4454,5282,5856,6196,6308,6418,6618,6893,8104,8338,9173,9637,9717,	
ATC 1 392 1 6752,	
analgésicos 1 392 1 1075,	
esteroideos 1 392 1 1073,	
antiinflamatorios 1 392 1 1071,	
salicilatos 1 392 1 1070,	
base 2 392 2 1068,3204,	
continuar 1 392 1 1064,	
Durante 8 392 8 1057,2672,3634,3946,4968,5205,5255,5436,	
16 3 392 3 1055,6855,8885,	
indican 1 392 1 4458,	
menores 1 392 1 1053,	
considera 1 392 1 1041,	
aprobadas 1 392 1 4898,	
refieran 1 392 1 2897,	
habitual 1 392 1 2222,	
Si 3 392 3 1039,1415,3164,	
concurrente 1 392 1 3293,	
considerado 1 392 1 1030,	
cuidadosamente 3 392 3 1029,2076,2297,	
beneficio/riesgo 1 392 1 1021,	
balance 1 392 1 1020,	
Por 4 392 4 1017,2070,2756,3613,	
recibir 6 392 6 1012,1082,1769,2414,8318,8381,	
depleción 10 392 10 1006,3011,3091,3525,3594,3668,3703,4650,6372,7032,	
fallo 8 392 8 1003,1663,1676,1682,2059,5296,5424,6369,	
observado 6 392 6 1002,1845,4875,5161,5515,6336,	
caso 8 392 8 997,1431,1433,1899,2385,2549,3315,3390,	
evaluará 2 392 2 2806,2919,	
Además 3 392 3 994,4548,6238,	
características 4 392 4 1651,4524,8350,9185,	
decisión 1 392 1 1435,	
alérgicas 4 392 4 984,2658,3473,6365,	
múltiples 4 392 4 3343,6307,6320,6626,	
relacionadas 12 392 12 976,1442,1848,3904,3983,4342,4397,4450,4472,4533,6132,6259,	
leve 3 392 3 1448,2499,4270,	
reacciones 54 392 54 975,983,1103,1324,1423,1441,1846,1904,1917,1938,1963,2001,2449,2482,2491,2513,2597,2601,2609,2657,2776,3472,3810,3892,3903,3961,3970,4052,4275,4292,4331,4341,4396,4471,4531,4553,5215,5288,5416,5914,5987,6003,6033,6039,6070,6096,6160,6203,6245,6357,6364,6390,6479,6523,	
agravamiento 1 392 1 972,	
asociada 4 392 4 969,2086,2648,4386,	
tumorales 2 392 2 1557,6801,	
HACA 3 392 3 966,999,9564,	
presencia 4 392 4 963,2639,7343,7355,	
(HACA) 2 392 2 951,2645,	
broncodilatadores 2 392 2 1896,2546,	
anti-quiméricos 3 392 3 950,2644,3468,	
humanos 3 392 3 949,2643,3465,	
anticuerpos 7 392 7 948,2642,3464,3482,6749,6854,6922,	
desarrollado 1 392 1 947,	
Algunos 1 392 1 944,	
anterior 3 392 3 936,2569,3291,	
12 9 392 9 931,2037,2815,3301,3637,3772,7017,7245,8752,	
2-5 1 392 1 925,	
retratados 2 392 2 7680,7726,	
repitió 1 392 1 921,	
continuada 1 392 1 916,	
evidencias 1 392 1 913,	
600 2 392 2 909,5842,	
aproximadamente 6 392 6 908,3954,4541,4705,5629,9170,	
observacional 1 392 1 907,	
inferior/neumonía 1 392 1 6227,	
cohortes 1 392 1 906,	
estudio 2 392 2 904,8597,	
respuestas 4 392 4 7182,7190,9400,9540,	
pequeño 1 392 1 903,	
RAF 2 392 2 5680,6333,	
En 38 392 38 901,1332,1363,1605,1746,1833,2553,2731,3203,3488,3672,3886,4030,4676,4762,4913,5024,5149,5323,5480,5504,5527,5543,5591,6667,6681,6987,7024,7117,7210,7465,7643,7732,7806,8290,8358,9063,9450,	
limitados 4 392 4 888,3435,6310,6629,	
clínicos 23 392 23 887,1783,2675,3138,3579,3851,3949,4134,4315,4417,4469,4916,5208,5546,5783,5799,6113,6314,6620,6670,6718,6734,7558,	
datos 18 392 18 886,1208,2708,2999,3133,3237,3434,3582,3846,4144,4179,4226,6309,6345,6619,6646,7553,7783,	
7 7 392 7 3538,3776,4963,7267,8009,8029,8888,	
Existen 1 392 1 885,	
periódicamente 1 392 1 884,	
controlado 2 392 2 7470,7648,	
monitorizar 3 392 3 883,1790,2075,	
1/10) 2 392 2 5978,5985,	
actividad 3 392 3 877,915,3806,	
humoral 1 392 1 2428,	
tarde 1 392 1 866,	
seguida 1 392 1 862,	
presumiblemente 1 392 1 2161,	
000 11 392 11 847,857,874,4086,5819,5863,6020,6505,6531,6730,7047,	
intravenosas 2 392 2 844,9722,	
compone 1 392 1 840,	
quimioterapias 1 392 1 823,	
eficacia 16 392 16 815,893,1212,3404,5785,7876,7927,8433,8494,8629,8826,8840,9151,9224,9580,9701,	
seguridad 10 392 10 813,891,1210,2399,2711,3143,3406,3835,6659,9583,	
establecido 2 392 2 811,3402,	
fracaso 1 392 1 7932,	
(en 1 392 1 3963,	
han 27 392 27 810,946,1844,1913,2007,2044,2224,2312,2595,2825,2963,3249,3325,3401,3562,3592,3685,3788,4348,4408,4770,4848,5160,5514,6199,6723,8130,	
primer 5 392 5 789,954,5461,7868,9140,	
usarse 1 392 1 772,	
1) 6 392 6 762,943,961,2671,3023,8530,	
apartado 16 392 16 760,959,1308,1514,1758,1860,2330,2484,2669,2699,2833,2915,3021,3161,3217,4027,	
(ver 20 392 20 759,937,958,1108,1288,1307,1513,1757,1859,2483,2668,2698,2832,2914,2990,3020,3160,3216,4026,8481,	
previo 3 392 3 734,7676,7794,	
oportunistas 1 392 1 2859,	
repetir 2 392 2 710,1042,	
semanas 16 392 16 705,758,864,1056,3070,4924,5143,5873,7151,7497,7595,7642,7692,7850,9123,9716,	
cuatro 8 392 8 704,757,3069,5441,7150,7691,8159,8169,	
semana 5 392 5 702,755,7071,7088,7148,	
eficaces 1 392 1 3653,	
intravenosa 16 392 16 698,751,802,861,871,1239,1894,1926,2472,2544,2589,5891,7144,7591,7688,9740,	
administrada 3 392 3 693,746,7456,	
recidivas 2 392 2 682,7290,	
subsiguientes 1 392 1 681,	
estén 2 392 2 676,3037,	
inicialmente 1 392 1 1402,	
sean 3 392 3 673,3821,4777,	
usado 1 392 1 659,	
años 7 392 7 651,4722,4757,4978,5640,5658,8423,	
periodo 9 392 9 647,3751,4759,5199,5438,5499,5830,8419,9332,	
progresión 12 392 12 640,4877,7199,7994,8426,8634,8648,8705,8858,9232,9375,9431,	
meses 40 392 40 638,932,3302,3514,3638,3773,4366,5202,5835,7003,7018,7209,7529,7623,7766,7903,7937,8006,8010,8030,8039,8082,8416,8455,8504,8606,8674,8688,8753,8835,8978,8982,9004,9008,9172,9259,9275,9293,9337,9651,	
vez 7 392 7 635,700,753,1420,1814,2579,7146,	
respondido 2 392 2 617,730,	
utiliza 1 392 1 599,	
respondieron 4 392 4 7405,7541,7635,7778,	
Monoterapia/Mantenimiento 1 392 1 591,	
procede 1 392 1 590,	
glucocorticoide 2 392 2 585,805,	
componente 2 392 2 584,804,	
intravenosadel 1 392 1 583,	
día 6 392 6 572,790,7839,7869,9112,9141,	
administrado 3 392 3 570,4921,8413,	
8 15 392 15 565,797,940,3539,3543,3824,7463,7496,7629,7765,7852,8229,8875,9125,9405,	
ciclo 16 392 16 563,576,793,836,935,955,1044,1116,1156,4641,5462,5825,7717,7872,9144,9404,	
corporal 6 392 6 561,633,692,745,787,8412,	
superficie 9 392 9 560,632,691,744,786,6833,6868,6933,8411,	
cardiaco 2 392 2 2060,5425,	
mg/m2 17 392 17 558,630,689,742,784,7139,7489,7586,7683,7827,7831,7858,8409,9097,9100,9104,9132,	
9449 1 392 1 8528,	
375 12 392 12 557,629,688,741,783,7138,7488,7585,7682,7857,8408,9131,	
log-rank 6 392 6 7946,8016,8048,8070,8664,8793,	
secciones 1 392 1 938,	
combinada 1 392 1 523,	
Terapia 2 392 2 522,8287,	
estándar 2 392 2 515,9094,	
aplicar 2 392 2 510,2103,	
administre 3 392 3 503,2194,7095,	
Cuando 3 392 3 500,2191,2278,	
crónicas 1 392 1 2903,	
reducciones 2 392 2 495,512,	
recomendadas 1 392 1 493,	
No 23 392 23 491,808,1214,2394,2706,2841,2997,3078,3106,3131,3310,3399,3560,3580,3786,4744,5120,5404,5465,6708,8218,8236,9537,	
durante 43 392 43 488,703,756,796,1592,1601,1743,1945,1978,2025,2186,2322,2633,2695,2791,2800,2836,3610,3710,3764,3770,3916,4093,4136,4414,4482,4487,4754,4922,5252,5459,5497,5637,5851,5905,7149,7495,7593,7690,7851,8417,9124,9330,	
Ajuste 1 392 1 485,	
incrementarse 2 392 2 470,1467,	
perfundidas 1 392 1 460,	
dosis 17 392 17 455,487,497,514,850,1158,1219,2705,3943,5860,6017,6725,6972,7116,7464,7551,8406,	
siguientes 12 392 12 454,993,1035,2667,2946,3303,3774,4406,4629,6197,6265,7442,	
Siguientes 1 392 1 451,	
400 4 392 4 449,483,1150,1186,	
RAFsnotificadas 1 392 1 4041,	
máximo 9 392 9 447,481,648,1148,1184,1404,7834,8420,9107,	
intervalos 3 392 3 438,472,1052,	
aumentar 5 392 5 436,1137,1173,3197,7068,	
minutos 8 392 8 433,444,478,1090,1134,1145,1181,1948,	
30 6 392 6 432,443,477,1133,1144,1180,	
primeros 3 392 3 431,1132,1947,	
después 30 392 30 428,579,933,952,985,1010,1129,1712,1922,2412,2659,2936,3015,3173,3506,3515,3639,3940,5144,5555,5655,5887,6052,6079,6395,6406,6487,6638,7019,7040,	
seguir 2 392 2 1785,3045,	
mg/h 13 392 13 427,441,450,467,475,484,1127,1142,1151,1171,1178,1187,2574,	
recomendada 8 392 8 421,548,594,654,708,780,851,1120,	
asoció 3 392 3 4662,5092,9510,	
inicial 11 392 11 420,464,1119,1168,1779,5776,7113,7342,7461,7546,7801,	
velocidad 10 392 10 419,463,1118,1167,1410,1459,1463,1613,2522,2568,	
náuseas 1 392 1 4507,	
verdaderas 1 392 1 1941,	
La 51 392 51 418,592,652,706,778,849,876,962,1117,1230,1462,2244,2333,2466,2487,2638,3060,3443,3530,3920,4389,4616,4788,5006,5617,5670,5727,5784,5908,6387,6509,6565,6594,6655,7152,7193,7306,7498,7596,7875,7890,7948,8018,8050,8150,8539,8547,8666,9244,9579,9697,	
Primera 2 392 2 416,1112,	
3) 1 392 1 2863,	
Hodgkin 2 392 2 415,2979,	
no- 3 392 3 414,2978,6764,	
urinario 2 392 2 4445,6593,	
incluya 1 392 1 407,	
administrar 8 392 8 401,1033,1050,1260,2532,2782,2892,2943,	
glucocorticoides 12 392 12 394,408,1069,1287,1902,1971,2469,2552,2619,6477,6512,6539,	
premedicación 7 392 7 392,1261,1285,2467,6510,6537,6560,	
considerar 10 392 10 390,1283,1428,1610,2032,2170,2365,2381,3370,3386,	
debe 22 392 22 389,568,771,882,1027,1049,1235,1259,1282,1312,1339,1366,1427,1609,1762,1789,2031,2169,2842,2954,3063,3618,	
Se 20 392 20 388,1311,1912,2043,2168,2223,2311,2824,2918,2962,3248,3550,3715,4564,4847,4873,4941,5131,5232,7374,	
reanimación 1 392 1 384,	
completo 1 392 1 382,	
equipo 1 392 1 381,	
(es 1 392 1 2853,	
inmediata 2 392 2 378,7033,	
cabo 1 392 1 3679,	
disponga 1 392 1 375,	
entorno 1 392 1 373,	
experiencia 4 392 4 369,2127,3208,6710,	
Sistémico 1 392 1 3276,	
médico 1 392 1 367,	
supervisión 1 392 1 364,	
internacional 1 392 1 8298,	
estrecha 1 392 1 363,	
Waldenstrom 1 392 1 5158,	
deben 19 392 19 359,509,1081,1248,1292,1579,1597,1739,1768,2074,2207,2294,2364,2620,3026,3181,3369,3649,3757,	
perfusiones 9 392 9 356,452,843,2511,3934,4628,5882,7044,9721,	
antígeno 6 392 6 6759,6775,6819,6841,6864,6953,	
indujo 1 392 1 4648,	
presentaban 1 392 1 912,	
Las 22 392 22 355,453,1157,1244,1440,1983,2000,2512,3691,3969,4051,4067,4089,4530,5881,5970,5986,6002,6038,6069,6582,8531,	
efecto 4 392 4 2096,6472,7361,9386,	
x 1 392 1 1561,	
administración 15 392 15 354,582,1229,1883,1925,1980,2588,2635,3075,3082,4247,6014,6274,6317,6968,	
forma 6 392 6 352,377,695,748,2180,2210,	
Posología 2 392 2 350,385,	
(TNF) 1 392 1 347,	
tumoral 9 392 9 346,1348,1549,1656,1728,1801,4529,4605,8542,	
reactiva 1 392 1 9688,	
MabThera/Rituximab 1 392 1 3616,	
necrosis 1 392 1 345,	
factor 1 392 1 343,	
antitumoral 1 392 1 7954,	
reactivación 4 392 4 2230,2969,4019,4852,	
inhibidores 3 392 3 341,3152,9634,	
Ann 1 392 1 9463,	
tratamientos 5 392 5 339,1831,2035,3116,9633,	
(FAMEs) 2 392 2 334,3105,	
enfermedad 27 392 27 333,643,880,919,2082,2261,2726,3104,3333,3351,4381,5399,5713,5719,7347,7357,7458,7547,7997,8357,8429,8651,8708,9192,9379,9434,9472,	
modificadores 2 392 2 330,3101,	
antirreumáticos 3 392 3 329,3100,3117,	
subgrupos 5 392 5 7214,8895,8925,9013,9453,	
fármacos 3 392 3 328,3099,3194,	
tracto 5 392 5 4444,6225,6230,6587,6592,	
intolerancia 2 392 2 324,9628,	
inadecuada 2 392 2 322,9626,	
respuesta 24 392 24 321,2427,6883,7155,7297,7371,7385,7670,7953,7956,8025,8139,8541,8553,8561,8564,8568,8579,8582,8585,8939,9371,9625,9711,	
presentado 1 392 1 319,	
primera 16 392 16 1603,1616,1708,1716,2687,3074,3918,4484,6055,6339,6409,6459,6490,6501,6971,8303,	
grave 10 392 10 316,1328,1519,1578,1624,1629,1756,2728,2852,2869,	
activa 4 392 4 315,2303,2850,9644,	
artritis 17 392 17 313,1079,2681,3129,3214,3321,3418,3457,3495,5779,5814,6104,6326,7027,9577,9595,9642,	
normales 4 392 4 6798,6812,6817,7011,	
Retratamiento 2 392 2 5740,7639,	
adultos 3 392 3 311,666,3054,	
metotrexato 6 392 6 303,3446,5793,5878,7102,9753,	
reumatoide 21 392 21 298,314,834,1080,1493,2437,2682,3130,3215,3322,3419,3458,3496,5780,5815,6105,6327,7028,9578,9596,9643,	
Artritis 4 392 4 297,833,1492,2436,	
5 19 392 19 295,761,942,960,2115,2670,3022,3421,4375,6062,6737,7263,7531,7626,7768,8038,8817,8886,8977,	
positivas 1 392 1 289,	
CD20 6 392 6 288,6760,6791,6835,6865,6954,	
grandes 5 392 5 287,769,832,9062,9090,	
B 36 392 36 286,768,831,1009,2293,2310,2973,3014,3094,3528,3568,3598,3671,3709,4023,4653,4856,6375,6772,6790,6797,6872,6892,6958,6979,6998,7036,7062,7132,7230,7482,7573,7661,9061,9089,9471,	
difuso 5 392 5 283,765,828,9058,9086,	
disponer 1 392 1 1953,	
prednisolona) 1 392 1 274,	
vincristina 5 392 5 273,2203,7828,8327,9101,	
doxorubicina 1 392 1 272,	
(ciclofosfamida 5 392 5 271,2202,7825,8325,9095,	
CHOP 24 392 24 270,777,807,2199,5061,5367,5413,5493,8207,8324,8335,8480,8496,8972,9037,9093,9134,9158,9280,9319,9349,9391,9396,9425,	
posterior 2 392 2 258,9322,	
segunda 9 392 9 256,679,869,988,1419,1710,2662,6082,8360,	
están 3 392 3 253,492,4035,	
quimiorresistentes 2 392 2 251,674,	
son 5 392 5 250,1871,4816,6627,7784,	
monoterapia 10 392 10 235,658,716,738,2093,2188,3866,4920,5212,7097,	
fallecimiento) 1 392 1 8653,	
sola 3 392 3 227,5037,5075,	
inducción 14 392 14 224,528,622,663,3870,5559,8322,8376,8473,8488,8930,8943,8970,8996,	
recién 1 392 1 3570,	
terapia 17 392 17 222,1024,3157,3176,3289,3355,3500,3518,4372,7544,7638,7781,8320,8374,8382,8968,8994,	
ciclos 17 392 17 566,798,896,926,992,1014,1036,2666,2945,5752,5848,6319,6398,6625,7700,7853,9126,	
respondan 1 392 1 219,	
74% 1 392 1 8511,	
refractario 6 392 6 217,538,614,726,8316,8467,	
(2%) 2 392 2 5443,6704,	
o 96 392 96 216,228,252,257,323,337,537,539,613,624,644,675,680,725,980,1074,1253,1330,1449,1481,1487,1498,1504,1528,1550,1691,1709,1725,1809,1895,2061,2200,2345,2430,2527,2545,2655,2725,2873,2881,2902,2904,3292,3467,3474,3485,3871,3881,4126,4135,4426,4569,4583,4587,4780,4800,5129,5385,5398,5698,5846,6361,6444,6448,6927,7098,7128,7134,7344,7351,7478,7485,7569,7582,7657,7664,7854,7998,8254,8315,8331,8370,8424,8466,8635,8652,8709,8932,8934,8945,9127,9231,9235,9627,9631,9690,	
recidiva 16 392 16 215,259,536,612,724,1787,7136,7283,7484,7581,7663,8314,8465,8647,9230,9445,	
mantenimiento 23 392 23 207,604,3875,4717,4761,4972,5259,5554,8289,8384,8394,8595,8613,8644,8679,8720,8762,8786,8798,8820,8915,8952,9019,	
previamente 5 392 5 199,544,7311,7821,9074,	
habían 15 392 15 729,2249,2338,2684,2981,4793,5937,5949,6107,6528,6558,7667,7697,9622,9708,	
tratados 22 392 22 198,545,1840,2067,2235,3336,3479,3861,4121,4765,5085,5105,5274,5308,5506,6579,6613,6698,6990,7820,7885,9076,	
desconocida 1 392 1 4571,	
sido 5 392 5 197,543,1811,4409,6200,	
hayan 7 392 7 196,318,542,616,1584,1807,1810,	
8% 1 392 1 5220,	
(leucoencefalopatía 1 392 1 4838,	
III-IV 3 392 3 193,248,671,	
estadio 4 392 4 192,247,670,9462,	
posología 6 392 6 547,593,653,707,779,3127,	
folicular 18 392 18 191,213,246,521,534,610,669,722,7110,7129,7479,7570,7653,7658,7818,8188,8312,8463,	
pacientes 164 392 164 187,209,242,279,310,530,606,665,718,910,945,1077,1222,1291,1319,1334,1545,1596,1607,1719,1748,1794,1839,2066,2078,2107,2140,2234,2248,2288,2337,2360,2375,2505,2679,2715,2732,2790,2846,2895,2953,2975,3007,3034,3087,3180,3212,3281,3319,3331,3365,3380,3455,3460,3493,3498,3510,3666,3848,3859,3887,3914,3951,3959,4118,4379,4465,4637,4659,4675,4764,4792,4864,4883,4904,4934,4967,5084,5104,5154,5223,5273,5307,5318,5359,5369,5442,5483,5505,5620,5661,5686,5691,5711,5717,5744,5761,5812,5820,5843,5857,5898,5935,5947,6051,6066,6102,6324,6383,6456,6486,6526,6578,6612,6680,6697,6989,7025,7085,7122,7203,7220,7252,7281,7309,7328,7398,7414,7472,7539,7560,7633,7650,7696,7724,7776,7815,7884,7899,7951,8089,8100,8309,8364,8439,8460,8589,8658,8905,8964,8990,9034,9041,9072,9155,9455,9520,9544,9557,9620,9638,9706,9718,9748,	
tratamiento 89 392 89 185,205,240,277,308,411,490,526,602,661,712,733,898,923,957,1016,1046,1059,1067,1083,1439,1594,1745,1770,2105,2415,2793,2838,2938,2948,3017,3041,3268,3411,3641,3766,3868,3873,3878,4643,4715,4970,5023,5174,5257,5440,5464,5479,5550,5557,5642,5775,5827,5850,5876,5901,6262,6322,6400,7005,7023,7407,7675,7702,7719,7793,7874,7934,7987,8056,8342,8392,8611,8642,8718,8784,8796,8879,8913,8941,8950,9017,9146,9177,9199,9240,9344,9388,9517,	
niños 2 392 2 1200,3603,	
quimioterapia 40 392 40 182,226,262,269,405,507,518,554,578,588,620,685,776,795,2089,2198,2254,2265,2285,2344,2988,3885,4050,4130,4388,4799,4871,5033,5036,5074,5089,5108,5332,5539,7455,7805,7823,8123,8185,9092,	
combinación 26 392 26 180,230,267,301,403,505,552,774,818,2196,2283,2342,2985,3883,4048,4128,4797,4869,5031,5330,5537,5790,7100,7803,7860,8118,	
indicado 5 392 5 178,202,237,265,305,	
está 8 392 8 177,201,236,264,304,1195,3107,6663,	
fallecimiento 6 392 6 2243,7999,8255,8710,8805,9229,	
(LNH) 1 392 1 175,	
no-Hodgkin 22 392 22 174,190,212,245,282,387,520,533,609,721,764,827,1337,1476,1543,2363,2992,5512,6787,7107,7109,9057,	
Linfoma 8 392 8 173,386,519,763,1475,1542,7108,9056,	
terapéuticas 2 392 2 172,1588,	
Indicaciones 1 392 1 171,	
	"4 1 392 1 169,	
CLÍNICOS 1 392 1 168,	
DATOS 1 392 1 167,	
diagnosticada 1 392 1 9652,	
4 55 392 55 166,348,939,1309,1452,1472,1515,1534,1535,1759,1861,2331,2485,2700,2834,2862,2916,2994,3162,3218,3420,3544,3775,3823,3999,4000,4005,4006,4012,4013,4028,4352,4712,4743,4923,4951,5142,5201,5241,5342,5422,6705,7115,7528,7550,7594,7625,7641,7769,7798,7830,8485,9103,9313,9419,	
incoloro 1 392 1 165,	
e 8 392 8 164,1634,2857,4153,4613,5099,5230,6139,	
transparente 1 392 1 163,	
líquido 1 392 1 162,	
función 1 392 1 2156,	
MabThera 153 392 153 159,176,200,232,233,263,299,358,396,457,499,501,550,567,596,626,656,714,736,770,820,838,853,900,1026,1038,1061,1093,1161,1193,1234,1279,1842,1880,1982,2029,2069,2091,2134,2190,2192,2327,2417,2445,2526,2593,2637,2690,2713,2741,2783,2804,2822,2840,2844,2893,2940,2950,3019,3043,3077,3113,3159,3178,3210,3265,3309,3338,3408,3442,3452,3508,3520,3576,3643,3700,3768,3795,3838,3864,3890,3945,4043,4123,4374,4432,4645,4647,4684,4719,4767,4795,4867,4918,4974,5029,5068,5087,5119,5152,5210,5276,5310,5328,5384,5508,5552,5590,5616,5636,5755,5788,5866,5884,5944,6023,6109,6217,6412,6581,6615,6700,6974,7050,7093,7141,7373,7491,7588,7678,7685,7796,7856,7864,8180,8333,8386,8396,8403,8615,8681,8722,8764,8788,8800,8828,8917,8954,9021,9130,9136,9585,9727,	
	Concentrado 1 392 1 154,	
FARMACÉUTICA 1 392 1 153,	
FORMA 1 392 1 152,	
afectación 4 392 4 7388,7400,7416,9476,	
tromboembólicos 2 392 2 5458,5474,	
3 20 392 20 151,637,1473,4297,4334,4741,5239,5340,5420,5839,7299,7532,7610,7849,8152,8162,8415,8687,8852,9122,	
6 15 392 15 149,929,3545,4401,5360,5834,7002,7179,7622,7772,7939,7940,8005,8981,9650,	
sección 10 392 10 148,294,2861,2993,3998,4004,4011,4322,4330,4340,	
ver 7 392 7 147,293,1906,2860,3997,4003,4010,	
excipientes 3 392 3 146,1486,1503,	
completa 5 392 5 144,1373,7957,8369,8562,	
lista 1 392 1 143,	
linfoma 24 392 24 189,211,244,281,413,532,608,668,720,826,1336,2362,2977,2991,3829,3840,5511,7106,7340,7817,8187,8881,9085,9234,	
consultar 1 392 1 141,	
Para 6 392 6 140,290,524,1903,4250,8587,	
viral 1 392 1 139,	
frecuentemente 5 392 5 1630,1704,2010,5226,5933,	
eliminación 1 392 1 138,	
sgrado 1 392 1 5681,	
1/1 1 392 1 4085,	
definen 2 392 2 4070,5973,	
inactivación 1 392 1 135,	
específicos 1 392 1 133,	
procedimientos 1 392 1 132,	
doble 3 392 3 5800,9604,9615,	
incluyendo 11 392 11 131,335,1349,1852,1920,2182,2592,2829,3273,3349,4737,	
iónico 1 392 1 130,	
así 3 392 3 2750,4696,8145,	
intercambio 1 392 1 129,	
afinidad 1 392 1 126,	
cromatografía 1 392 1 124,	
mediante 1 392 1 123,	
purifica 1 392 1 122,	
chino) 1 392 1 119,	
322 1 392 1 7814,	
hámster 1 392 1 118,	
ovario 1 392 1 116,	
(células 1 392 1 114,	
mamífero 1 392 1 113,	
células 30 392 30 111,285,767,830,1008,1556,2352,3527,3597,3670,4652,4807,6374,6789,6796,6805,6808,6810,6891,6939,6978,6997,7035,7061,7131,7481,7572,7660,9060,9088,	
suspensión 1 392 1 109,	
cultivo 1 392 1 107,	
partir 2 392 2 104,1394,	
produce 1 392 1 102,	
Tratamiento 6 392 6 7112,7460,7545,7800,8190,8274,	
Este 4 392 4 99,1644,6818,7423,	
murinas 3 392 3 98,1491,1508,	
pesadas 1 392 1 97,	
ligeras 1 392 1 94,	
cadenas 2 392 2 93,96,	
flutter 2 392 2 2055,2755,	
variable 4 392 4 90,7924,8626,9698,	
secuencias 1 392 1 86,	
humana 1 392 1 83,	
Monoterapia 1 392 1 7111,	
revirtieron 1 392 1 2515,	
IgG1 1 392 1 82,	
administrarse 5 392 5 360,1236,1249,2843,3619,	
constantes 1 392 1 79,	
regiones 1 392 1 78,	
glucosilada 2 392 2 75,6765,	
aleatorizados 7 392 7 4679,8110,8171,8440,8590,9156,9602,	
inmunoglobulina 1 392 1 74,	
representa 3 392 3 72,9283,9354,	
genética 1 392 1 70,	
ingeniería 1 392 1 69,	
obtenido 1 392 1 67,	
murino/humano 1 392 1 66,	
quimérico 1 392 1 65,	
monoclonal 1 392 1 64,	
anticuerpo 4 392 4 63,100,6827,9551,	
monodosis 1 392 1 54,	
clínico 2 392 2 2393,3398,	
vial 1 392 1 53,	
Cada 2 392 2 52,835,	
urticaria/rash 2 392 2 4508,6430,	
Rituximab 4 392 4 51,59,60,6754,	
mg/ml 1 392 1 49,	
10 4 392 4 48,1835,7576,7752,	
biológicos) 1 392 1 3505,	
contiene 2 392 2 47,55,	
completamente 2 392 2 1816,2581,	
	Cada 1 392 1 45,	
CUANTITATIVA 1 392 1 44,	
Y 1 392 1 43,	
CUALITATIVA 1 392 1 42,	
COMPOSICIÓN 1 392 1 41,	
región 1 392 1 89,	
2 24 392 24 40,326,349,4324,4721,4977,5639,5657,5859,5872,6016,6077,6092,6169,7836,7984,8212,8422,8673,8854,9109,9303,9409,9466,	
58% 2 392 2 8525,8526,	
perfusión 86 392 86 39,158,417,424,697,750,801,860,870,979,989,1107,1113,1123,1153,1238,1251,1277,1316,1369,1399,1413,1445,1461,1465,1604,1617,1717,1765,1851,1878,1951,2027,2042,2441,2452,2494,2524,2530,2560,2654,2663,2688,2697,2779,2802,2820,3307,3907,3919,3928,3986,4345,4400,4453,4475,4485,4536,4623,5148,5254,5382,5890,5942,6037,6042,6056,6073,6083,6135,6195,6360,6394,6410,6417,6427,6491,6502,6549,7143,7493,7590,7687,8400,9735,9739,	
solución 6 392 6 37,46,156,1231,1892,2542,	
administraron 1 392 1 5886,	
concentrado 1 392 1 35,	
mg/ml) 1 392 1 34,	
(10 1 392 1 33,	
mg 17 392 17 32,57,848,858,875,1086,5864,5894,6021,6506,6532,6731,7048,7837,9110,9725,9743,	
100 11 392 11 31,56,466,474,1085,1170,1177,2573,3541,5893,9742,	
	MabThera 1 392 1 30,	
MEDICAMENTO 2 392 2 29,6742,	
NOMBRE 1 392 1 27,	
PRODUCTO 1 392 1 24,	
DEL 2 392 2 23,28,	
grupo 20 392 20 5117,5355,5365,5446,5491,5593,5614,5634,5647,7905,7973,7981,8033,8042,8091,8102,8760,8770,9413,9423,	
CARACTERÍSTICAS 1 392 1 22,	
LAS 1 392 1 21,	
DE 2 392 2 20,6740,	
RESUMEN 1 392 1 19,	
Tampoco 1 392 1 2418,	
O 1 392 1 18,	
pre-existente 1 392 1 5400,	
TÉCNICA 1 392 1 17,	
FICHA 1 392 1 16,	
tuvo 1 392 1 4260,	
ocasiones 1 392 1 2539,	
información 2 392 2 13,292,	
investigador 1 392 1 8546,	
Toda 1 392 1 11,	
cardiovascular 3 392 3 2727,5403,5454,	
medicamento 5 392 5 10,15,1268,5917,6099,	
Basica 1 392 1 8,	
	Información 1 392 1 7,	
síndrome 19 392 19 1302,1345,1572,1619,1645,1653,1701,1751,1798,1825,1854,1907,1932,1993,3988,3993,4526,4602,4606,	
ML 1 392 1 6,	
50 8 392 8 5,426,440,1126,1141,2576,8235,9099,	
VIAL 1 392 1 4,	
1 34 392 34 3,25,26,150,170,296,573,846,856,873,2114,4111,4316,4956,4962,5370,5818,5862,6019,6504,6530,6729,6744,7046,7829,7840,8097,8873,9007,9102,9113,9566,9567,9610,	
MG 1 392 1 2,	
500 1 392 1 1,	
MABTHERA 1 392 1 0,	
